Robert F. Kennedy Jr., President Donald Trump’s nominee for the US Department of Health and Human Services, has informed the Senate Finance Committee that he will divest his interest in litigation related to the HPV vaccine Gardasil. This decision comes as an update to his previous ethics agreement, which had raised concerns about potential financial benefits from the outcome of the litigation.
In response to senators’ questions during the confirmation hearings, Kennedy stated, 'An amendment to my Ethics Agreement is in process, and it provides that I will divest my interest in this litigation.' The issue of vaccines and Kennedy's financial ties to questioning their safety were prominent topics during the hearings.
